| 11/18/2026 3:35 PM | Beltran Pedro (2058152) Reporting BridgeBio Oncology Therapeutics (1869105) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/17/2026 3:35 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Cobo Marc (1816654) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2026 3:24 PM | BridgeBio Oncology Therapeutics (1869105) Subject Cobo Marc (1816654) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2026 2:31 PM | BridgeBio Oncology Therapeutics (1869105) Subject Flynn James E (1352546) Filed by | Form SCHEDULE 13G/A | |
| 11/10/2026 3:21 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/23/2026 3:15 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Cobo Marc (1816654) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 3:11 PM | Ben Yong (1967669) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 3:12 PM | Beltran Pedro (2058152) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 3:13 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Elmelech Idan (2058437) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 3:14 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Cobo Marc (1816654) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 11:15 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form EFFECT | |
Get the Latest News and Ratings for BBOT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BridgeBio Oncology Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/08/2026 11:15 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form EFFECT | |
| 09/08/2026 3:19 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/01/2026 4:15 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/01/2026 3:02 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form POS AM | |
| 08/11/2026 3:07 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/06/2026 5:00 PM | Beltran Pedro (2058152) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 5:00 PM | Ben Yong (1967669) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 5:00 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Elmelech Idan (2058437) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 5:00 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Cobo Marc (1816654) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 3:34 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Chen Bihua (1599214) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:26 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 06/22/2026 3:05 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 3:57 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Lebowitz Peter F (2121402) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 3:58 PM | BridgeBio Oncology Therapeutics (1869105) Issuer MCCORMICK FRANK (1257809) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 3:59 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Tipirneni Praveen P. (1779978) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 3:01 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 05/12/2026 4:11 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/12/2026 4:07 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 05/05/2026 6:01 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Mehra Uneek (1881504) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 6:03 PM | Beltran Pedro (2058152) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 6:05 PM | Ben Yong (1967669) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 11:15 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form EFFECT | |
| 04/30/2026 4:25 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form POS AM | |
| 04/30/2026 3:17 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Cobo Marc (1816654) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/29/2026 3:05 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:06 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form DEF 14A | |
| 03/26/2026 4:14 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Lebowitz Peter F (2121402) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:52 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/26/2026 3:54 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
URGENT: If you own a home, please review the map below. (Ad) More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them.
Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power.
Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it. See the map and get the full details on what this means for you |
| 03/12/2026 3:56 PM | Ben Yong (1967669) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:57 PM | Beltran Pedro (2058152) Reporting BridgeBio Oncology Therapeutics (1869105) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:58 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Mehra Uneek (1881504) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 5:01 AM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 03/05/2026 3:40 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/05/2026 3:15 PM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 6:09 AM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 6:12 AM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 01/07/2026 6:15 AM | BridgeBio Oncology Therapeutics (1869105) Filer | Form 424B3 | |
| 01/05/2026 6:22 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Wallace Eli M. (1776352) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 6:04 PM | BridgeBio Oncology Therapeutics (1869105) Issuer Wallace Eli M. (1776352) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |